Understanding in depth how tumors evolve to become malignant is the objective of a study recently published in the journal ...

Understanding in depth how tumors evolve to become malignant is the objective of the latest study led by the Cell Plasticity ...

Recently, Prof. Huang Qing's group from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences studied ...

Good Morning America’ meteorologist Sam Champion returned to work Friday, October 18, following a skin cancer scare that ...

On the Friday, October 18, episode of Good Morning America, the beloved weatherman gave viewers an inside look into his skin ...

Yousef Zakharia, MD, discussed some of the available combination therapies for non–clear Cell renal cell carcinoma treatment.

A new paper from Elham Azizi's lab and collaborators has been accepted for publication in Genome Research, marking a ...

A recent study has revealed that chloride flow through channels on the surface of tumor cell lines plays a crucial role in ...

Behind breast cancer, prostate cancer is the second most common cancer in the United States. Since its opening in 2012, the ...

The TIMING™ platform, supported by AI, enables advanced label-free cell analysis for cancer immunotherapy. By observing ...

Circulating tumor DNA is a promising tool for the detection and surveillance of HPV-positive oropharyngeal squamous cell ...

The U.S. Food and Drug Administration approved Astellas' therapy to treat a type of gastric cancer, the health regulator's ...